SFX by Ex Libris Inc.

Title:	Synthesis and Pharmacology of Galantamine
Source:	Chemical Reviews [0009-2665] Marco Contelles, José yr:2006

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mukherjee, Pulok K. "Acetylcholinesterase inhibitors from plants." Phytomedicine 14.4 (2007): 289-300.
description	2.	Zhao, Chun-An M. "An Efficient Total Synthesis of (+/-)-Stemonamine." Organic letters 10.9 (2008): 1763-1766.
description	3.	Wellbery, C. "Effect of Galantamine on Patients with Dementia." American family physician 71.11 (2005): 2187-2188.
description	4.	Sousa, M. E. "Synthesis of xanthones: An overview." Current medicinal chemistry 12.21 (2005): 2447-2479.
description	5.	Galasko, D. "Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease." Journal of the American Geriatrics Society 52.7 (2004): 1070-1076.
description	6.	Mukherjee, Pulok K K. "Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity." Phytotherapy research 21.12 (2008): 1142-5.
description	7.	Frankowski, K. "Syntheses of the Stemona alkaloids (+/-)-stenine, (+/-)-neostenine, and (+/-)-13-epineostenine using a stereodivergent Diels-Alder/azido-Schmidt reaction." Journal of the American Chemical Society 130.18 (2008): 6018-6024.
description	8.	Zhang, H. "Total Synthesis of (Â±)-Strychnine via a [4 + 2]-Cycloaddition/Rearrangement Cascade." Organic letters 9.2 (2007): 279-282.
description	9.	Cyrus, I. "Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living." Journal of geriatric psychiatry and neurology 13.1 (2000): 9-16.
description	10.	Spiegel, G.. "Rivastigmine in Alzheimer Disease: Efficacy Over Two Years." The American journal of geriatric psychiatry 12.4 (2004): 420-431.
description	11.	Akhondzadeh, S. "Herbal medicine in the treatment of Alzheimer's disease." American journal of Alzheimer's disease and other dementias 21.2 (2006): 113-118.
description	12.	Kinnecom, C. "Course of cerebral amyloid angiopathy-related inflammation." Neurology 68.12 (2007): 1411-6.
description	13.	Zhao, J. "One-pot synthesis of xanthones and thioxanthones by the tandem coupling - Cyclization of arynes and salicylates." Organic letters 7.19 (2005): 4273-4275.
description	14.	Nicholson, Wayne T. "Sugammadex: a novel agent for the reversal of neuromuscular blockade." Pharmacotherapy 27.8 (2007): 1181-8.
description	15.	Houghton, Peter J. "Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease." Neuro-Signals 14.1-2 (2005): 6-22.
description	16.	Jones, Roy W W. "A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease." International journal of geriatric psychiatry 19.1 (2003): 58-67.
description	17.	Zimmer, R. "Alkoxyallenes as building blocks for organic synthesis." Chemical Society reviews 43.9 (2014): 2888-903.
description	18.	Fromentin, Y. "Yeast-Mediated Xanthone Synthesis through Oxidative Intramolecular Cyclization." Organic letters 14.19 (2012): 5054-5057.
description	19.	Pedro, M. "Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro." Bioorganic & medicinal chemistry 10.12 (2002): 3725-3730.
description	20.	Kurz, A. "Non-cognitive benefits of galantamine (ReminylReg.) treatment in vascular dementia." Acta neurologica Scandinavica 106.Suppl178 (2002): 19-24.